Published in Am J Kidney Dis on September 21, 2008
Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol (2011) 1.61
Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis (2011) 1.58
The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol (2012) 1.02
Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.01
Infectious complications in dialysis--epidemiology and outcomes. Nat Rev Nephrol (2011) 1.00
Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis. Clin J Am Soc Nephrol (2012) 1.00
Factors affecting employment at initiation of dialysis. Clin J Am Soc Nephrol (2011) 0.96
A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. Clin J Am Soc Nephrol (2011) 0.96
Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea. PLoS One (2013) 0.93
Microbiology of peritonitis in peritoneal dialysis patients with multiple episodes. Perit Dial Int (2012) 0.91
The Current State of Peritoneal Dialysis. J Am Soc Nephrol (2016) 0.90
Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective. Appl Health Econ Health Policy (2014) 0.88
Dialysis Modality and Mortality in the Elderly: A Meta-Analysis. Clin J Am Soc Nephrol (2015) 0.87
Effect of body mass index on outcomes of peritoneal dialysis patients in India. Perit Dial Int (2014) 0.86
Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. NDT Plus (2009) 0.83
The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis. BMC Nephrol (2014) 0.81
Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review. Evid Based Complement Alternat Med (2015) 0.79
Dialysis: The importance of peritoneal catheter exit-site care. Nat Rev Nephrol (2010) 0.78
Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis. Perit Dial Int (2012) 0.77
Clinical significance of red blood cell distribution width in the prediction of mortality in patients on peritoneal dialysis. Kidney Res Clin Pract (2016) 0.77
Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age. Pediatr Nephrol (2016) 0.76
Comparing the Effect of Dressing Versus No-dressing on Exit Site Infection and Peritonitis in Chronic Ambulatory Peritoneal Dialysis Patients. Adv Biomed Res (2017) 0.75
Peritoneal dialysis outcomes of Indigenous Australian patients of remote Kimberley origin. Aust J Rural Health (2014) 0.75
Outcomes of Infection-Related Hospitalization according to Dialysis Modality. Clin J Am Soc Nephrol (2015) 0.75
Is female sex really a risk factor for infectious death in peritoneal dialysis? Perit Dial Int (2013) 0.75
The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis. Perit Dial Int (2014) 0.75
Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes. PLoS One (2016) 0.75
Increased peritoneal dialysis exit site infections using topical antiseptic polyhexamethylene biguanide compared to mupirocin: results of a safety interim analysis of an open-label prospective randomized study. Antimicrob Agents Chemother (2013) 0.75
Baseline Predictors of Mortality among Predominantly Rural-Dwelling End-Stage Renal Disease Patients on Chronic Dialysis Therapies in Limpopo, South Africa. PLoS One (2016) 0.75
Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled Cases. Mycopathologia (2017) 0.75
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
The effect of obesity on renal transplant outcomes. Transplantation (2002) 2.29
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol (2012) 2.06
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients? Transplantation (2002) 1.98
Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
Reduction in cardiovascular death after kidney transplantation. Transplantation (2010) 1.89
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis (2011) 1.71
Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68
Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67
The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int (2009) 1.66
The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Perit Dial Int (2012) 1.63
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis (2009) 1.61
Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61
Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59
Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol (2014) 1.57
Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int (2011) 1.56
Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant (2008) 1.55
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int (2012) 1.53
The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation (2004) 1.52
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant (2007) 1.51
Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int (2009) 1.49
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47
Post-kidney transplant weight change as marker of poor survival outcomes. Transplantation (2008) 1.46
Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int (2010) 1.45
Waiting time and outcome of kidney transplantation in adolescents. Transplantation (2006) 1.44
Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) (2005) 1.43
Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) (2011) 1.41
Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients. Transpl Int (2010) 1.39
Racial disparities in pediatric kidney transplantation in New Zealand. Pediatr Transplant (2014) 1.38
Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol (2005) 1.37
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol (2013) 1.36
Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant (2008) 1.35
Laparoscopic placement of peritoneal dialysis catheters: 7 years experience. ANZ J Surg (2003) 1.32
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31
Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis (2010) 1.31
Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) (2007) 1.28
The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant (2008) 1.27
Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int (2003) 1.26
Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation (2007) 1.26
Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant (2010) 1.24
Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (2010) 1.24